[go: up one dir, main page]

AU2001244700A1 - Process for producing amine derivatives - Google Patents

Process for producing amine derivatives

Info

Publication number
AU2001244700A1
AU2001244700A1 AU2001244700A AU4470001A AU2001244700A1 AU 2001244700 A1 AU2001244700 A1 AU 2001244700A1 AU 2001244700 A AU2001244700 A AU 2001244700A AU 4470001 A AU4470001 A AU 4470001A AU 2001244700 A1 AU2001244700 A1 AU 2001244700A1
Authority
AU
Australia
Prior art keywords
amine derivatives
secretion
inhibiting
accumulation
action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001244700A
Other languages
English (en)
Inventor
Kaneyoshi Kato
Hiroyuki Tawada
Makoto Yamashita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2001244700A1 publication Critical patent/AU2001244700A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
AU2001244700A 2000-04-03 2001-04-02 Process for producing amine derivatives Abandoned AU2001244700A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-105398 2000-04-03
JP2000105398 2000-04-03
PCT/JP2001/002845 WO2001074756A1 (fr) 2000-04-03 2001-04-02 Procede de production de derives d'amine

Publications (1)

Publication Number Publication Date
AU2001244700A1 true AU2001244700A1 (en) 2001-10-15

Family

ID=18618765

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001244700A Abandoned AU2001244700A1 (en) 2000-04-03 2001-04-02 Process for producing amine derivatives

Country Status (11)

Country Link
US (1) US6784314B2 (fr)
EP (1) EP1270545B1 (fr)
KR (1) KR100769504B1 (fr)
CN (4) CN1680280A (fr)
AT (1) ATE413379T1 (fr)
AU (1) AU2001244700A1 (fr)
CA (1) CA2404736C (fr)
CY (1) CY1108727T1 (fr)
DE (1) DE60136446D1 (fr)
ES (1) ES2312423T3 (fr)
WO (1) WO2001074756A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4354180B2 (ja) * 2001-12-26 2009-10-28 武田薬品工業株式会社 軽度認知障害治療剤
NZ550441A (en) * 2004-05-05 2009-07-31 Hoffmann La Roche Arylsulfonyl benzodioxanes useful for modulating the 5-HT6 receptor, the 5-HT2A receptor or both
WO2006001463A1 (fr) 2004-06-23 2006-01-05 Ono Pharmaceutical Co., Ltd. Composé ayant une activité de liaison aux récepteurs s1p et utilisation de celui-ci
AU2005318596B2 (en) * 2004-12-21 2010-12-23 F. Hoffmann-La Roche Ag Chroman derivatives and their use as 5-HT receptor ligands
BRPI0515830A (pt) 2004-12-21 2008-08-05 F Hoffmann La Roche derivados de cromano e usos dos mesmos no tratamento de distúrbios do sistema nervoso central
DK1831159T3 (da) * 2004-12-21 2010-03-22 Hoffmann La Roche Tetralin og indanderivater samt anvendelser deraf
KR100889185B1 (ko) * 2004-12-21 2009-03-16 에프. 호프만-라 로슈 아게 테트랄린 및 인단 유도체 및 5-ht 길항제로서의 이의용도
BRPI0515835A (pt) * 2004-12-21 2008-08-12 Hoffmann La Roche derivados de tetralina e de indano e seus usos
ATE499355T1 (de) * 2005-11-03 2011-03-15 Hoffmann La Roche Arylsulfonylchromane als 5-ht6-inhibitoren
CA2653758A1 (fr) * 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Derives tetraline et indane et leurs utilisations
WO2007147763A1 (fr) * 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Dérivés arylsulfonylnaphtalène et leurs utilisations
KR101064001B1 (ko) * 2006-06-20 2011-09-08 에프. 호프만-라 로슈 아게 아릴설폰아미딜 테트랄린 유도체 및 이의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3630903A1 (de) 1986-09-11 1988-03-24 Thomae Gmbh Dr K Neue tetrahydronaphthalin- und indanderivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
DE3807813A1 (de) 1988-03-10 1989-09-21 Thomae Gmbh Dr K Neue benzocycloheptenderivate, diese verbindungen enthaltende arzneimittel und verfahren zu deren herstellung
DE3901814A1 (de) 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
DK0589037T3 (da) 1991-03-01 1996-09-16 Zeria Pharm Co Ltd Indanderivat og thromboxanantagonist indeholdende samme
EP0763034A1 (fr) 1994-05-28 1997-03-19 Smithkline Beecham Plc Derives amide a activite antagoniste par rapport a 5ht1d
ES2098186B1 (es) 1995-02-09 1998-02-01 Consejo Superior Investigacion Composiciones farmaceuticas a base de aminometilindoles para su aplicacion terapeutica como neuroprotectores en las enfermedades de parkinson y alzheimer.
US6225352B1 (en) 1996-08-14 2001-05-01 Warner-Lambert Company Low molecular weight dendritic compounds as pharmaceutical agents
US6048877A (en) 1997-02-21 2000-04-11 Bristol-Myers Squibb Company Tetralone derivatives as antiarrhythmic agents
DE69839305T2 (de) 1997-02-27 2009-04-09 Takeda Pharmaceutical Co. Ltd. Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta
JP3868096B2 (ja) * 1997-02-27 2007-01-17 武田薬品工業株式会社 アミン誘導体、その製造法および剤
JP4367982B2 (ja) * 1997-07-18 2009-11-18 武田薬品工業株式会社 光学異性体の製造法

Also Published As

Publication number Publication date
CA2404736A1 (fr) 2002-10-02
CN101058543A (zh) 2007-10-24
CY1108727T1 (el) 2014-04-09
CN1680332A (zh) 2005-10-12
US6784314B2 (en) 2004-08-31
ATE413379T1 (de) 2008-11-15
EP1270545A4 (fr) 2005-10-12
CA2404736C (fr) 2011-12-06
CN100486957C (zh) 2009-05-13
CN1680280A (zh) 2005-10-12
EP1270545B1 (fr) 2008-11-05
CN1422244A (zh) 2003-06-04
CN100349872C (zh) 2007-11-21
US20030139602A1 (en) 2003-07-24
WO2001074756A1 (fr) 2001-10-11
KR100769504B1 (ko) 2007-10-23
DE60136446D1 (de) 2008-12-18
ES2312423T3 (es) 2009-03-01
KR20020089424A (ko) 2002-11-29
EP1270545A1 (fr) 2003-01-02
CN101058543B (zh) 2010-05-26

Similar Documents

Publication Publication Date Title
CY1108727T1 (el) Διαδικασια παραγωγης αμινικων παραγωγων
AU7335896A (en) Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same
ES2188661T3 (es) Preparacion de un derivado de camptothecin por ciclacion intramolecular.
EP2460884A3 (fr) Procédé de préparation de monatine
MY133531A (en) Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds
PT1265888E (pt) Processo para producao de derivados de (s)-nicotina 6-substituida e compost0s intermediarios
ATE231160T1 (de) Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel
MXPA03010960A (es) Proceso para la produccion de fexofenadina derivado de piperidina.
BR0212772A (pt) Processo para a preparação de repaglinida
EA200200101A1 (ru) Получение замещенных пиперидин-4-онов
DK0717042T3 (da) Fremgangsmåde til fremstilling af 1-(4,5-dihydro-2-thiazolyl)-3-azetidin-thiol-derivater
PL336053A1 (en) Novel derivatives of amino pyridine, methods of obtaining them, methods obtaining (4-(2-(2-(6-aminopyridin-3-yl(-2(r)-hydroxyethylamino)ethoxy)phenyl) acetic acid, its novel polymorphous form and pharmaceutic agent
PT965588E (pt) Processo de preparacao de derivados de 4-fenil-1,2,3,6-tetra-hidropiridina e os produtos intermediarios utilizados no processo
EP0947499A3 (fr) Procédé de préparation de la sertraline racémique
PT1358179E (pt) Processo de sintese e intermediarios de piridin-2-il-metilamina
BR9705662A (pt) Piridinas substituìdas.
DE69921795D1 (de) Verfahren zur herstellung von benzothiophencarbonsäureamid-derivaten
WO2002100829A3 (fr) Procede de preparation de paroxetine sensiblement exempte d'impuretes alcoxy
HRP20020021B1 (en) Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates
DE60105216D1 (de) Verfahren zur Herstellung von aromatischen Acylthiocarbonsäurederivaten
EP1229029A4 (fr) Procede de production d'un compose de benzylamine
EP1179532A4 (fr) Production de derives indole et intermediaires a cet effet
DE69912282D1 (de) Verfahren zur herstellung eines indolderivates
CA2281244A1 (fr) Procede de preparation de sels acides de trovafloxacine
IT1318465B1 (it) Processo per la preparazione di decaidro-2a, 4a,6a,8a-tetraazaciclopent(fg)acenaftilene e derivati funzionalizzati.